Most women with cancer want a role in decisions

February 9, 2012 — NEW YORK (Reuters Health) - About two-thirds of women diagnosed with early stage breast cancer want to take part in making decisions about their treatment, according to a new survey of patients from five different countries.

Cancer trial participants may have misconceptions

February 9, 2012 — NEW YORK (Reuters Health) - People enrolled in early stage trials for possible cancer treatments may underestimate the risks involved and overestimate the potential benefits, suggests a new study.

Breast cancer kills older women more often

February 7, 2012 — NEW YORK (Reuters Health) - Breast cancer is often considered more deadly among younger women, but a new study shows older women are actually more likely to die of the disease.

Ovarian cancer screening popular despite guidelines

February 6, 2012 — NEW YORK (Reuters Health) - Despite expert guidelines and scientific evidence to the contrary, a third of U.S. primary care physicians believe ovarian cancer screening is effective and many would offer it to patients, according to a new survey.

UK says home-grown cancer pill too costly to use

February 2, 2012 — LONDON (Reuters) - Britain's health cost watchdog NICE sparked a major row on Thursday by snubbing a pricey new prostate cancer pill discovered at the country's top cancer research center, a decision critics said was bad for patients and research.

CORRECTION: Seed therapy for prostate cancer may zap fertility

February 1, 2012 — NEW YORK (Reuters Health) - Radioactive "seeds" that are sometimes used to treat early prostate cancer may do widespread damage to the DNA in a man's sperm, a small study finds.

Seed therapy for prostate cancer may zap fertility

February 1, 2012 — NEW YORK (Reuters Health) - Radioactive "seeds" that are sometimes used to treat early prostate cancer may do widespread damage to the DNA in a man's sperm, a small study finds.

Crab-like robot built to remove stomach cancer

February 1, 2012 — SINGAPORE (Reuters) - Inspired by Singapore's famous chilli crab dish, researchers have created a miniature robot with a pincer and a hook that can remove early-stage stomach cancers without leaving any scars.

Breast cancer charity ends Planned Parenthood funding

February 1, 2012 — The Komen Foundation, best-known for the Race for the Cure fundraisers it sponsors around the country each year, did not immediately respond to a request for comment from Reuters.

Diabetes drugs tied to pancreatic cancer risk

January 31, 2012 — NEW YORK (Reuters Health) - A new study links the diabetes drug metformin to fewer cases of pancreatic cancer -- at least in women -- but finds other diabetes medications are associated with a higher risk of the disease.

U.S. FDA approves Roche skin cancer drug

January 30, 2012 —

Arsenic cancer risk still high decades later

January 24, 2012 — NEW YORK (Reuters Health) - People exposed to very high levels of arsenic in Chilean drinking water back in the 1950s and 60s are still showing a higher-than-normal risk of bladder cancer -- years after the arsenic problem was brought under control, a new study shows.

FDA approves BTG's drug for cancer toxicity

January 18, 2012 — WASHINGTON (Reuters) - U.S. health regulators gave the nod on Tuesday to a drug from British specialty drugmaker BTG Plc that helps cancer patients get rid of toxic levels of a chemotherapy treatment.

China cancer village tests law against pollution

January 16, 2012 — XIAOXIN, China (Reuters) - Nothing in Wu Wenyong's rural childhood hinted he would end up on a hospital bed aged 15, battling two kinds of cancer.

Cancer drug gets stronger label warning

January 13, 2012 —